journal article·2016-01-11Open access

Materializing the future of vaccines and immunotherapy

Darrell J. Irvine

Nature Reviews Materials· Volume 1· Issue 1

Abstract

Materials science has the potential to overcome some of the grand challenges facing the fields of immunology and immunotherapy. The floodgates are poised to open. Biomaterials have the potential to solve problems in immunology; from the targeted delivery of immunomodulatory cancer drugs to monitoring the immune system.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Immunotherapy and Immune Responses · CAR-T cell therapy research · Monoclonal and Polyclonal Antibodies Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (5)

Show source-provided references
1. Mellman, I., Coukos, G. & Dranoff, G. Cancer immunotherapy comes of age. Nature 480, 480–489 (2011).10.1038/nature10673 ↗
2. Cheung, A. S. & Mooney, D. J. Engineering materials for cancer immunotherapy. Nano Today http://dx.doi.org/10.1016/j.nantod.2015.06.007 (2015).10.1016/j.nantod.2015.06.007 ↗
3. Mascola, J. R. & Haynes, B. F. HIV-1 neutralizing antibodies: understanding nature's pathways. Immunol. Rev. 254, 225–244 (2013).10.1111/imr.12075 ↗
4. Boesch, A. W., Alter, G. & Ackerman, M. E. Prospects for engineering HIV-specific antibodies for enhanced effector function and half-life. Curr. Opin. HIV AIDS 10, 160–169 (2015).10.1097/COH.0000000000000149 ↗
5. Kwong, G. A. et al. Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease. Nat. Biotechnol. 31, 63–70 (2013).10.1038/nbt.2464 ↗